Literature DB >> 25093964

Virtual reality exposure therapy for the treatment of anxiety disorders: an evaluation of research quality.

Russell A McCann1, Christina M Armstrong1, Nancy A Skopp1, Amanda Edwards-Stewart1, Derek J Smolenski1, Jennifer D June1, Melinda Metzger-Abamukong1, Greg M Reger2.   

Abstract

Randomized controlled trials (RCTs) support the effectiveness of virtual reality exposure therapy (VRET) for anxiety disorders; however, the overall quality of the VRET RCT literature base has yet to be evaluated. This study reviewed 27 VRET RCTs and the degree of adherence to 8 RCT research design criteria derived from existing standards. Adherence to the study quality criteria was generally low as the articles met an average 2.85 criteria (SD=1.56). None of the studies met more than six quality criteria. Study quality did not predict effect size; however, a reduction in effect size magnitude was observed for studies with larger sample sizes when comparing VRET to non-active control groups. VRET may be an effective method of treatment but caution should be exercised in interpreting the existing body of literature supporting VRET relative to existing standards of care. The need for well-designed VRET research is discussed.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Adherence; Effectiveness; Randomized controlled trials

Mesh:

Year:  2014        PMID: 25093964     DOI: 10.1016/j.janxdis.2014.05.010

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  35 in total

Review 1.  The Use of Virtual Reality Technology in the Treatment of Anxiety and Other Psychiatric Disorders.

Authors:  Jessica L Maples-Keller; Brian E Bunnell; Sae-Jin Kim; Barbara O Rothbaum
Journal:  Harv Rev Psychiatry       Date:  2017 May/Jun       Impact factor: 3.732

Review 2.  [Development of virtual reality as an exposure technique].

Authors:  Julia Diemer; Peter Zwanzger
Journal:  Nervenarzt       Date:  2019-07       Impact factor: 1.214

Review 3.  Virtual Reality and Medical Inpatients: A Systematic Review of Randomized, Controlled Trials.

Authors:  Julieta Dascal; Mark Reid; Waguih William IsHak; Brennan Spiegel; Jennifer Recacho; Bradley Rosen; Itai Danovitch
Journal:  Innov Clin Neurosci       Date:  2017-02-01

Review 4.  Review of Virtual Reality Treatment in Psychiatry: Evidence Versus Current Diffusion and Use.

Authors:  Matthew C Mishkind; Aaron M Norr; Andrea C Katz; Greg M Reger
Journal:  Curr Psychiatry Rep       Date:  2017-09-18       Impact factor: 5.285

Review 5.  Recent Progress in Virtual Reality Exposure Therapy for Phobias: A Systematic Review.

Authors:  Cristina Botella; Javier Fernández-Álvarez; Verónica Guillén; Azucena García-Palacios; Rosa Baños
Journal:  Curr Psychiatry Rep       Date:  2017-07       Impact factor: 5.285

Review 6.  [Virtual reality exposure therapy for anxiety disorders].

Authors:  Y Shiban
Journal:  Nervenarzt       Date:  2018-11       Impact factor: 1.214

7.  Posttraumatic Stress Disorder Treatment Effects on Cardiovascular Physiology: A Systematic Review and Agenda for Future Research.

Authors:  Kyle J Bourassa; Rebecca C Hendrickson; Greg M Reger; Aaron M Norr
Journal:  J Trauma Stress       Date:  2020-12-05

8.  Harnessing the Spatial Foundation of Mind in Breaking Vicious Cycles in Anxiety, Insomnia, and Depression: The Future of Virtual Reality Therapy Applications.

Authors:  Ravinder Jerath; Connor Beveridge
Journal:  Front Psychiatry       Date:  2021-07-08       Impact factor: 4.157

Review 9.  Immersive Virtual Environment Technology to Supplement Environmental Perception, Preference and Behavior Research: A Review with Applications.

Authors:  Jordan W Smith
Journal:  Int J Environ Res Public Health       Date:  2015-09-11       Impact factor: 3.390

10.  Is Continued Improvement After Automated Virtual Reality Exposure Therapy for Spider Phobia Explained by Subsequent in-vivo Exposure? A First Test of the Lowered Threshold Hypothesis.

Authors:  Philip Lindner; Peter Dafgård; Alexander Miloff; Gerhard Andersson; Lena Reuterskiöld; William Hamilton; Per Carlbring
Journal:  Front Psychiatry       Date:  2021-05-20       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.